Page 37 - Delaware Medical Journal - March/April 2021
P. 37

             TREATMENT
   staff training was available to address management of residents with BPSD, 18 (90.0%) of 20 respondents answered 
Table 3 shows that among 19 LTCFs
that responded to questions regarding changes in behavioral consultation
and the use of pharmacologic or non- pharmacologic interventions during
          behavioral consultation or pharmacologic      no change in non-pharmacologic interventions. Behavioral consultation       (31.6%) of these responders during
the pandemic, and non-pharmacologic
          
DISCUSSION
      
Delaware’s LTCFs admit and provide
     
about half the residents are reported to
     
or does not accept new residents with
     
the effects described as “aging in place.” All responding facilities indicated that multiple BPSD among their residents
          wandering as top BPSD issues for their      disruptive, approaches to their treatment are available. These facilities reported use of multiple strategies, both pharmacologic and non-pharmacologic, in managing BPSD. The use of multiple strategies
                approach for this problem.
Non-Pharmacologic Treatment Methods
       Person Centered Care Presence Therapy Sensory Stimulation Reminiscence Psychotherapy Environmental Adaptation Music Therapy Tailored Activity Validation Therapy Cognitive Stimulation Therapy Verbal Psychotherapy Sensory Gardens Animal Therapy Aromatherapy Touch Therapy Behavioral Psychotherapy Dance Therapy Massage Therapy Bright Therapy Robot Therapy
Anti-depressant Medications Anti-anxiety Medications Anti-psychotic Medications Anti-convulsant Sleeping Pills Cognitive Enhancers Other
FIGURE 1
0 5 10 15 20 25 30 Facility
Pharmacologic Treatment Methods
0 5 10 15 20 25 Facility
                                   Number of Facilities Reporting Treatment Interventions (24 Responders)
   TABLE 3: Changes in BPSD Intervention Approaches During COVID-19 Pandemic
 APPROACHES
 OVERALL SAMPLE (N=19)
 Behavioral Consultation, n (%)
  14.4 (14.0-14.7)
 Increase
 3 (15.8)
 Decrease
 6 (31.6)
 Unchanged
  10 (52.6)
   Pharmacologic Intervention, n (%)
 Increase
 3 (15.8)
 Decrease
 4 (21.1)
 Unchanged
 12 (63.1)
 Non-Pharmacologic Intervention, n (%)
  Increase
 8 (42.1)
 Decrease
 3 (15.8)
 Unchanged
 8 (42.1)
     Del Med J | March/April 2021 | Vol. 93 | No. 2 85
Method Method













































   35   36   37   38   39